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ABSTRACT 
The  widespread  adoption  of  high  dose  rate  brachytherapy  with  its  inherent  dangers  necessitates  adoption  of 
appropriate quality assurance measures to minimize risks to both patients and medical staff. This paper is aimed at 
assisting someone who is establishing a new program or revising one already in place into adhere to the recently issued 
Nuclear Regulatory Commission (USA) regulations and the guidelines from the American Association of Physicists in 
Medicine. © 2006 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Within five years of its discovery by the Curies in 
1898,  Ra 226  was  being  successfully  used  in 
brachytherapy [1]. For the next 50 odd years, radium was 
the  isotope  of  choice  for  brachytherapy  applications, 
finally  yielding  to  reactor produced  nuclides  such  as 
cobalt, cesium, and iridium with much shorter half lives. 
These  γ ray  emitters,  known  as  “radium  substitutes”, 
were at first used in low dose rate (LDR) implants (< 200 
cGy/hr; typically 40 to 80 cGy/hr). More recently, the 
ability to produce high specific activity Ir 192 sources 
combined  with  developments  in  computer  controlled 
after loader technology has led to widespread adoption of 
high dose rate (HDR) techniques, i.e. > 1200 cGy/hr [1]. 
The advantages of HDR treatments include  
●  greater ease and comfort for the patient (often 
as an out patient),  
●  more precise dose delivery,  
●  easier dose shaping, and  
●  less exposure to medical personnel.  
However, because of the dangers of using a source 
with very high activity (10 Ci), it is of utmost importance 
to  have  proper  quality  assurance  (QA)  procedures  in 
place  along  with  the  required  dosimetric  and  planning 
equipment,  and  appropriately  trained  staff.  This  guide 
focuses primarily on the first (QA procedures) and the 
third (training) in this list. It is intended to assist those 
who are in the process of establishing a program in HDR 
brachytherapy. 
Since each country regulates its own medical use of 
radioactive  material,  it  is  the  duty  of  the  medical 
physicist to establish a quality management program to 
satisfy  those  regulations.  The  focus  of  this  review  is 
regulations of the US Nuclear Regulatory Commission, 
as  contained  in  10  CFR  Part  10  (medical  use  of 
byproduct material) [2] and recommendations made by 
the  American  Association  of  Physicists  in  Medicine 
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(AAPM). The latter are intended to provide the medical 
physicist in the USA (and it is hoped other nations as 
well) the proper guidance to ensure that brachytherapy 
procedures are carried out safely and with due attention 
to  these  rules.  There  are  two  AAPM  task  group  (TG) 
reports that are particularly relevant to HDR QA. They 
are TG 56: Code of practice for brachytherapy physics 
[3], and especially TG 59: HDR brachytherapy treatment 
delivery [4]. Another useful reference for brachytherapy 
quality assurance has been published by ESTRO and is 
available on their website [5]. This paper will provide 
details about HDR QA as it is performed in our radiation 
therapy  department  (on  a  Nucletron  Microselectron 
system) and how the QA program is related to the NRC 
regulations and the task group recommendations. 
 
APPLICATOR QA 
Prior  to  the  initial  use  of  a  new  (or  replacement) 
applicator, it is necessary to verify that the source dwell 
positions  correspond  to  the  radiographic  marker 
positions used in simulation and treatment planning. TG 
56  recommends  that  coincidence  of  dummy  and 
radioactive sources be checked annually as well. There 
are many standard applicators; photographs of several of 
those used in our institution are shown in Figure 1.   
The  method  we  employ  to  verify  coincidence  of 
dwell  position  and  radiographic  marker  is 
autoradiography.  An  applicator  is  taped  securely  to  a 
sealed film envelope (Figure 2) and the HDR after loader 
is programmed to send the source to a few appropriately 
chosen dwell positions for less than 1 second (e.g. 0.3 s 
for 0.31 GBq source). Next, the film plus applicator is 
transferred  to  a  diagnostic  X ray  source  such  as  a 
simulator, the dummy source markers are placed in the 
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Figure 1  Examples of HDR applicators used for lung, rectal, and gynecologic diseases. 
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applicator and the film exposed and developed (e.g. 125 
kVp, 125 mAs for Kodak XV film). An example of this 
is  shown  in  Figure  3.  TG 56  recommends  that  the 
coincidence of dummy and active sources be within 2 
mm; the NRC regulations call for ± 1 mm. 
PERIODIC SPOT-CHECK 
The new NRC regulations require a periodic spot 
check  of  each  HDR  unit  prior  to  the  first  use  on  any 
given day that the after loader is in operation and after 
each new source installation. These spot checks need not 
be  done  by  the  authorized  medical  physicist,  but  the 
latter must review the results and notify the licensee in 
writing of his findings. Table 1 lists the checks that must 
be performed at a minimum to assure proper operation of 
the unit according to NRC Regulations 10 CFR Part 35. 
A  convenient  way  of  implementing  and  recording 
the above quality assurance is by using a checklist such 
as the one our clinic uses as shown in figure 4. 
Certain  tests  require  only  a  simple  inspection  to 
ensure  that  materials  are  present,  viz.  User  manual, 
Removal  kit,  Emergency  instructions,  Bailout  pig, 
Radiation alarm setting, and Printer paper.  Switching on 
the system allows the tests in item 7 to be performed. 
The  source  activity  comparison  can  be  made  using  a 
table generated by the medical physicist (Figure 5). This 
will  also  satisfy  the  requirement  (see  Full  Calibration 
below) for performing decay correction which must be 
done  by  the  authorized  medical  physicist.  Agreement 
should easily be within 1 percent tolerances. 
For the remaining tests, the active source will need 
to be deployed. For this, the system can be programmed 
manually each time or a standard program recalled from 
the system memory. A single dwell time of 20 to 30 s 
suffices to test the door interlock, the interrupt button, 
and the emergency off button as well as to verify that the 
appropriate  exposure  indicators  and  radiation  monitors 
are functioning properly. The spot check form requires 
testing of the functioning of the meter in the treatment 
room  (Figure  6)  under  battery  power  alone.  Its  alarm 
setting  of  4  mR/hr  was  established  so  as  to  be  above 
exposure  levels  in  the  room  due  to  an  adjacent  linac 
therapy suite. As an additional safety measure, we have a 
calibrated GM meter that is carried by hand by personnel 
upon entering the treatment room. It is checked using a 1 
mCi Cs 137 source that yields a 10 mR/hr contact value. 
The remaining item is an estimate of timer accuracy. For 
this, a stopwatch is used to time a 30 s dwell. Typical 
error estimates are well below 1 second. 
FULL CALIBRATION 
A “full calibration” is mandated for several different 
circumstances, e.g. before first medical use, following a 
source change or any major repair, etc. Since the source 
in most, if not all, modern HDR after loaders is Ir 192 
with  a  half life  of  approximately  74  days,  the 
requirement  for  quarterly  calibration  [2]  does  not 
formally apply. However, it is usual to replace an iridium 
source  four  times  a  year  so  as  to  maintain  reasonable 
dose rates and treatment times. Quarterly QA testing of 
HDR after loaders was recommended in the report of TG 
56. The components of a full calibration as defined in 
NRC Regulations 10 CFR Part 35 are listed in Table 2. 
 
Figure 2  Photograph of a ring applicator secured to a base plate 








Figure 3  Autoradiograph of a 3 cm ring showing 5 dwell 
positions (1,5,9,13,17) as well as the intervening 
dummy markers (unnumbered arrows).  Dwell positions 
are for the 0.5 cm step size. 
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The form we employ for the full calibration is on an 
Excel  spreadsheet  (Figure  7)  which  allows  convenient 
calculations of source activity and positioning as well as 
timer accuracy and linearity. The activity of the source is 
measured using a well chamber and electrometer having 
calibrations  traceable  to  the  National  Institute  of 
Standards and Technology (within 2 years as indicated 
by the dates on the form). The electrometer needs to be 
calibrated in both current and charge (integral) modes. 
The source is programmed to go to a series of positions 
within  the  well  chamber  and  the  maximum  current 
reading is used to calculate the activity in air kerma units. 
This value is then compared to the manufacturer’s stated 
activity decayed to the day of measurement. Agreement 
is typically within 2%. The regulations allow a 5% range. 
If equipment calibrations traceable to a national standard 
are not available, dosimetry system constancy checks can 
be performed using a long lived source such as Cs 137 
[5].  This  is  not  a  desirable  substitute  for  proper 
calibration. 
Positioning  accuracy  is  measured  using  a  special 
ruler  supplied  by  the  manufacturer  (Figure  8).  The 
programmed position (e.g. 995) is for the center of the 
source,  hence  the  correction  (one half  of  the  source 
length, or 2.15 mm) for the leading edge. The one mm 
criterion may not be satisfied if there is much curvature 
in the measuring system (see Figure 9). Thus, some care 
must  be  taken  to  ensure  that  the  transfer  tube  is 
reasonably straight and horizontal. 
We perform the battery back up test by shutting off 
the AC power to the after loader while a source has been 
deployed.  This  makes  it  a  somewhat  different  test 
compared  to  the  one  in  the  spot check  where  the 
emergency off button is pushed. That the source has been 
retracted  is  printed  out  at  the  control  console  and  is 
verified  by  the  radiation  monitor  indicating  exposure 
rates below the set value (4 mR/hr). 
Timer  error  and  linearity  are  measured  using  a 
technique established for teletherapy sources. Charge is 
collected and measured in the well chamber for a set of 
predetermined  times.  The  pass/fail  criteria  we  adopted 
seem both reasonable and reproducible and well within 
the capability of the system.  
We test the integrity of the transfer tube/applicator 
system in three ways.  
●  Once  a  program  has  been  loaded  into  the 
control  unit,  a  transfer  tube  +  applicator  is 
attached to Channel 1 but the indexer ring is not 
locked.  
●  The second test has the transfer tube removed 
from Channel 1 and the ring locked.  
●  The final test has the transfer tube inserted into 
Channel 1, the ring locked, and an applicator 
with an obstruction in it attached. It should be 
added that in the Nucletron system, failure to 
connect  the  transfer  tube  to  the  applicator 
properly  will  usually  generate  the  same  error 
code as an obstruction. 
 
Figure 4  Spot check form used each day of patient treatment. A 
downloadable  version  is  available  at  http://www.biij. 
org/2006/2/e34/fig4.asp 
 
Figure 5  Source decay on physicist generated spreadsheet (left) 
and printout from the HDR control console (right).  The 
actual numbers for the particular treatment date are 
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TREATMENT PLANNING QUALITY ASSURANCE 
It is standard practice in external beam radiotherapy 
to  have  a  second,  independent  check  of  the  treatment 
plan  and  monitor  unit  calculations.  This  may  take  the 
form of a simplified algorithm using data from phantom 
measurements  or  dose  measurements  inside  a  suitable 
phantom (especially for IMRT plans). For brachytherapy, 
the  independent  check  is  also  desirable  (but  not 
mandated by NRC regulation), but there is no generally 
accepted  method  for  doing  it.  Some  characteristic 
parameter(s)  of  the  plan  must  be  compared  to  an 
expected  value;  however,  what  the  characteristic 
parameters should be and how to arrive at the expected 
value  are  left  to  each  medical  physicist  or  institution. 
TG 59  addresses  these  issues  and  lists  several 
approaches  that  have  appeared  in  the  literature  [6 8]. 
Typically, the dose is calculated at representative points 
by the treatment planning system and then compared to 
the results from a second independent system (perhaps a 
spreadsheet  or  nomogram).  It  remains  unclear  what 
agreement is acceptable. Our method has been to use a 
plot of treatment time x source activity/ dose versus the 
global  parameter  of  treatment  volume  for  various 
applicator types. This is similar to the Paterson Parker 
tables  from  the  days  of  radium  sources.  It  has  been 
described previously [9] and will be summarised below.  
The  treatment  volume  (usually  V100  in  our 
experience) is obtained from the dose volume histogram 
(DVH). Several plans were run on both the Plato and a 
second  treatment  planning  system  and  the  respective 
DVH’s compared to lend credibility to the use of this 
parameter.  We, then, used data from 20 to 30 patient 
plans  for  each  of  several  applicator  types  (vaginal 
cylinder, tandem/ring, endobronchial tube) to construct 
the  T*A/D  vs  V100  plots.  Several  cases  for  each 
applicator were double planned with a second treatment 
planning  system  (ROCS  or  Pinnacle)  for  verification 
purposes.  The  data  on  each  graph  were  then  fitted  to 
either a straight line or a second order polynomial using 
statistical  methods.  The  result  was  then  used  for 
checking  new  patient  plans  to  ensure  consistency.  A 
summary of the initial use of this method for two types 
of applicators is shown in Table 3. 
Clearly, the agreement is better when a polynomial 
is used for fitting the reference data. A similar situation 
is found for other types of applicators as well. 
Perhaps an even more important aspect of treatment 
plan quality assurance is to have a second trained person 
inspect the plan and compare it with the written directive. 
The comparison should include such items as the dose 
prescription (per fraction and per course of treatment), 
the step size, dwell positions, etc. A more complete list is 
to be found in the report of TG 59. A check list that is 
part of the patient’s chart is a practical method to ensure 
that  this  aspect  of  quality  control  is  performed. 
Examination of other input data such as simulator films 
and comparison with the treatment plan is also essential. 
In  our  institution,  specially  trained  radiation  therapy 
technologists and the authorized user physician check the 
treatment plan. 
 
Figure 6  Exposure rate meter mounted on a wall in the treatment 
room so as to be visible from the entrance way. 
 
                                     HDR FULL CALIBRATION 
                                     Nucletron MicroSelecton HDR S/N 9213
Date: December 5,2005 Time: 10:20
1.  SOURCE ACTIVITY 
Chamber: Standard Imaging HDR 1000 Plus; S/N A943623
Electrometer:  CNMC K602; S/N 51090 
Source # Stated activity Reference date Check date Decayed act
D35A 2870 41250 11/17/2005 12/5/2005 34852.6471
T = 23.2 C t,p: 1.0188
P = 749 Calibration factor: 4921 Calibrated:  Apr 05
Electrometer factor: 0.981 Calibrated:  Oct 04
Electr. rdgs






 Measured activity (U) 35003.72 8.68 Ci
Ratio:  measured/stated activity 1.0043
_____  within ± 5%
2.  SOURCE POSITIONING ACCURACY (Mode 13)
Programmed Measured Actual Deviation
Distance (mm) Distance (mm) Distance ( 2.15mm) (mm)
905 907.5 905.35 0.35
995 997 994.85 -0.15
_____ within 1 mm
3.  BATTERY BACK-UP
_____ Source retracted from treatment position when power to the unit was interrupted
_____  Printout indicated failure due to power interruption and gave source out time and position 
4.  LENGTH OF SOURCE TRANSFER TUBES & APPLICATORS (changes < 1 mm)
_____  transfer tubes for flexible applicators_____  transfer tubes for rigid applicators
_____  transfer tubes for gyn applicators _____ applicators
5.  TIMER ACCURACY & LINEARITY     d = 950mm
 
Time (s) Q x 10
 7 Slope =  Q/ T Timer Error =
(Q2 2Q1) T/(Q2 Q1)
5 3.755
10 7.176 0.6842 -0.4882
20 14.006 0.683 -0.5066
_____  timer error < 1 s  
Figure 7  Full calibration spreadsheet with actual calibration data. 
A downloadable version is available at http://www.biij. 
org/2006/2/e34/fig7.asp DA Wilkinson. Biomed Imaging Interv J 2006; 2(2):e34    6 
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TRAINING OF PERSONNEL 
The clinical personnel involved in an HDR program 
include the authorized user physician, authorized medical 
physicist, radiation safety officer, dosimetrist, nurse, and 
radiation therapy technologist. Some of these roles may 
be  combined  into  one.  For  example,  the  medical 
physicist may act also as the radiation safety officer and 
do the treatment planning in lieu of a dosimetrist. The 
authorized  physician  and  medical  physicist  should  be 
certified by the appropriate medical specialties board and 
have  had  special  training  in  brachytherapy.  Of  prime 
importance  is  the  radiation  safety  training  that  all 
personnel involved in HDR treatments undergo. This is 
administered to new personnel and then annually for all 
those in the HDR program. Included is training in the 
proper  response  to  a  major  emergency,  in  particular, 
failure of the source to be retracted into the after loader 
safe upon completion of treatment or upon power outage. 
The  daily  spot  check  should  ensure  that  proper 
equipment (removal kit and bailout pig) is in place and 
that simple emergency instructions are posted so as to be 
readily  available.  If  the  source  has  to  be  retracted 
manually, the standard precepts of radiation safety, viz. 
time,  distance,  and  shielding,  should  be  followed.    If 
operation  of  the  hand  crank  is  unsuccessful,  then  the 
applicator containing the stuck source has to be removed 
from  the  patient.  Once  again,  speed  is  crucial  as  is 
having  such  items  as  long  forceps  and  a  flashlight  on 
hand.  With  the  applicator  plus  source  placed  in  the 
bailout  pig  and  the  patient  and  medical  personnel 
removed from the treatment room, the HDR suite should 
be secured and a service engineer contacted for repair. 
We find it useful at the time of the annual training to 
review and discuss in detail what each member of our 
brachytherapy  team  would  do  in  various  emergency 
situations. 
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Table 1  Mandated periodic spot checks. 
1.  Electrical interlocks at entrance to room 
2.  Source exposure indicator lights on the after loader, control console, and in the 
facility 
3.  Viewing and intercom systems 
4.  Emergency response equipment 
5.  Radiation monitors to indicate source position 
6.  Timer accuracy 
7.  Clock (date and time) in unit’s computer 





Table 2  Full calibration measurements (as applicable). 
1.  Output within ± 5% 
2.  Source positioning accuracy to within ± 1 mm 
3.  Source retraction with backup battery upon power failure 
4.  Length of the source transfer tubes 
5.  Timer accuracy and linearity over the typical range of use 
6.  Length of the applicators 











average difference  n 
vaginal cylinder  5.45±.06%  2.76±.01%  34 
tandem/ring  4.56±.02%  2.48±.02%  40 
 
 